Pelubide Tablet (Pelubiprofen)

Adult dose

Adults: Take 1 tablet (equivalent to 30mg of pelubiprofen) orally 3 times daily after meals.

Patients who regularly consume more than three glasses of alcohol per day must consult a doctor or pharmacist before taking this medication, as there is a risk of gastrointestinal bleeding. Non-steroidal anti-inflammatory drugs, including this medication, may affect the cardiovascular system, increasing the risk of serious cardiovascular problems such as myocardial infarction or stroke. Caution should be exercised, especially in individuals with cardiovascular diseases or risk factors, and if symptoms occur, medical personnel should be notified immediately. This medication can cause serious issues such as gastrointestinal bleeding, ulcers, and perforations, so elderly patients and those with a history of gastrointestinal diseases should be particularly cautious when taking it. If gastrointestinal symptoms occur, treatment should be sought immediately, and in some cases, discontinuation of this medication may be necessary. Patients with a history of peptic ulcers, severe blood disorders, significantly impaired liver or kidney function, severe heart failure, or hypertension, as well as those allergic to the drug components, should not take this medication. Individuals who have had allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs, those wanting pain relief after coronary artery bypass surgery, breastfeeding mothers, and those with specific inherited metabolic disorders should also avoid this medication. Particular caution is needed for patients with a history of peptic ulcers, blood disorders, bleeding tendencies, liver or kidney dysfunction, heart dysfunction, hypertension, asthma, systemic lupus erythematosus, ulcerative colitis, Crohn's disease, and especially among the elderly and children when using this medication. This medication may cause various side effects, including headaches, dizziness, drowsiness, skin rash, dyspepsia, abdominal pain, nausea, vomiting, edema, blood pressure changes, and respiratory difficulties. If any abnormal symptoms appear, immediate consultation with a doctor is required. This medication should be used for the shortest time and at the minimum dose possible. Patients with chronic diseases should undergo regular blood tests and liver and kidney function assessments. It should be used in conjunction with treatment for acute diseases and long-term use should be avoided. This medication should not be taken with other anti-inflammatory drugs, and it may interact with certain blood pressure medications, antibiotics, anticoagulants, lithium, and methotrexate, so patients should inform their doctor or pharmacist of any other medications they are taking. It is advisable not to take this medication during pregnancy, especially in the late stages, as it may pose a risk to the fetus. Use after the 20th week of pregnancy may affect the fetal kidney function and should be done with caution under the doctor's direction. Breastfeeding mothers should not take this medication, as it may be transmitted through breast milk. Safety in children has not been established, requiring caution in use, and elderly patients should start with a small dose and monitor their condition closely for side effects. This medication should be stored out of reach of children, and transferring it to another container may pose a risk of accidents or quality degradation; therefore, it should be stored in its original container.

• Gastrointestinal bleeding
• cardiovascular thromboembolic events
• myocardial infarction
• stroke
• bleeding from the stomach or intestines
• ulcers
• perforation
• edema
• abdominal pain
• heartburn

This medication is sensitive to light and should be stored in a tightly closed container that protects it from light. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's efficacy and safety over time.

Appearance

Pale yellow round tablet

Package unit

For domestic use: 30 tablets/bottle, 300 tablets/bottle, for export: 20 tablets (10 tablets/PTP x 2), 30 tablets (10 tablets/PTP x 3), 100 tablets (10 tablets/PTP x 10)